dehydroepiandrosterone has been researched along with Hyperthyroid in 15 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We examined serum concentrations of ADIOL, ADIOLS, DHEA, DHEAS and pregnenolone sulfate (5-pregnen-3beta-ol-20-one sulfate, PREGS) in patients with Graves' thyrotoxicosis (male/female 9/14), hypothyroidism (11/20) and in normal controls (14/29)." | 7.71 | Serum concentration of androstenediol and androstenediol sulfate in patients with hyperthyroidism and hypothyroidism. ( Amino, N; Fukata, S; Izumi, Y; Kobayashi, Y; Kuma, K; Tada, H; Tagawa, N; Takano, T, 2001) |
| "Dehydroepiandrosterone (DHEA) and DHEA-sulphate (S) have been suggested to play protective roles in many pathological states, some of which are observed in hyperthyroidism." | 7.71 | Dehydroepiandrosterone sulphate is increased and dehydroepiandrosterone-response to corticotrophin-releasing hormone is decreased in the hyperthyroid state compared with the euthyroid state. ( Akai, A; Hayashi, M; Kokubo, Y; Murai, T; Yamakita, N; Yasuda, K, 2001) |
| " We examined serum concentrations of ADIOL, ADIOLS, DHEA, DHEAS and pregnenolone sulfate (5-pregnen-3beta-ol-20-one sulfate, PREGS) in patients with Graves' thyrotoxicosis (male/female 9/14), hypothyroidism (11/20) and in normal controls (14/29)." | 3.71 | Serum concentration of androstenediol and androstenediol sulfate in patients with hyperthyroidism and hypothyroidism. ( Amino, N; Fukata, S; Izumi, Y; Kobayashi, Y; Kuma, K; Tada, H; Tagawa, N; Takano, T, 2001) |
| "Dehydroepiandrosterone (DHEA) and DHEA-sulphate (S) have been suggested to play protective roles in many pathological states, some of which are observed in hyperthyroidism." | 3.71 | Dehydroepiandrosterone sulphate is increased and dehydroepiandrosterone-response to corticotrophin-releasing hormone is decreased in the hyperthyroid state compared with the euthyroid state. ( Akai, A; Hayashi, M; Kokubo, Y; Murai, T; Yamakita, N; Yasuda, K, 2001) |
| "Dehydroepiandrosterone (DHEA) is a peroxisome proliferating agent when administered in pharmacological dosages, but it has not been shown to function through the peroxisome proliferator-activated receptor in cell-based assays." | 1.29 | Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. ( Geoghegan, TE; Prough, RA; Webb, SJ; Xiao, GH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamanti-Kandarakis, E | 1 |
| Dattilo, M | 1 |
| Macut, D | 1 |
| Duntas, L | 1 |
| Gonos, ES | 1 |
| Goulis, DG | 1 |
| Gantenbein, CK | 1 |
| Kapetanou, M | 1 |
| Koukkou, E | 1 |
| Lambrinoudaki, I | 1 |
| Michalaki, M | 1 |
| Eftekhari-Nader, S | 1 |
| Pasquali, R | 1 |
| Peppa, M | 1 |
| Tzanela, M | 1 |
| Vassilatou, E | 1 |
| Vryonidou, A | 1 |
| Maggi, M | 1 |
| Buvat, J | 1 |
| Corona, G | 1 |
| Guay, A | 1 |
| Torres, LO | 1 |
| Skjöldebrand Sparre, L | 1 |
| Kollind, M | 1 |
| Carlström, K | 1 |
| KRUESKEMPER, HL | 1 |
| KESSLER, FJ | 1 |
| HASSAN, SH | 1 |
| Webb, SJ | 1 |
| Xiao, GH | 1 |
| Geoghegan, TE | 1 |
| Prough, RA | 1 |
| Bobyleva, V | 1 |
| Bellei, M | 1 |
| Kneer, N | 1 |
| Lardy, H | 1 |
| Tagawa, N | 2 |
| Tamanaka, J | 1 |
| Fujinami, A | 1 |
| Kobayashi, Y | 2 |
| Takano, T | 2 |
| Fukata, S | 2 |
| Kuma, K | 2 |
| Tada, H | 2 |
| Amino, N | 2 |
| Izumi, Y | 1 |
| Yamakita, N | 1 |
| Murai, T | 1 |
| Kokubo, Y | 1 |
| Hayashi, M | 1 |
| Akai, A | 1 |
| Yasuda, K | 1 |
| Abdel Gadir, A | 1 |
| Khatim, MS | 1 |
| Mowafi, RS | 1 |
| Alnaser, HM | 1 |
| Muharib, NS | 1 |
| Shaw, RW | 1 |
| Sneddon, A | 1 |
| Steel, JM | 1 |
| Strong, JA | 1 |
| Garmendia, F | 1 |
| Nicolis, GL | 1 |
| Gabrilove, JL | 1 |
| Felt, V | 1 |
| Strasek, J | 1 |
| Bednár, J | 1 |
| Solomon, S | 1 |
| Friesen, HG | 1 |
| Takahara, J | 1 |
| Hashimoto, K | 1 |
| Ofuji, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Antioxidants vs.Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve[NCT03621683] | 78 participants (Actual) | Interventional | 2016-01-06 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for dehydroepiandrosterone and Hyperthyroid
| Article | Year |
|---|---|
MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview.
Topics: Adjuvants, Immunologic; Aging; Androgens; Antioxidants; Circadian Rhythm; Dehydroepiandrosterone; Di | 2017 |
Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA).
Topics: Acromegaly; Adrenal Insufficiency; Dehydroepiandrosterone; Gonadotropins; Hormone Replacement Therap | 2013 |
Endocrine relations between mother and fetus.
Topics: Aldosterone; Angiotensin II; Animals; Biological Transport, Active; Breast; Dehydroepiandrosterone; | 1968 |
12 other studies available for dehydroepiandrosterone and Hyperthyroid
| Article | Year |
|---|---|
Ovarian ultrasound and ovarian and adrenal hormones before and after treatment for hyperthyroidism.
Topics: Adrenal Cortex Hormones; Adult; Antithyroid Agents; Dehydroepiandrosterone; Dehydroepiandrosterone S | 2002 |
[Analysis of the antithyrotoxic effects of a protein-anabolic testosterone derivative (1-methyl-delta1-androstenolone)].
Topics: Androgens; Dehydroepiandrosterone; Humans; Hyperthyroidism; Proteins; Steroids; Testosterone; Testos | 1961 |
Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.
Topics: Animals; Blotting, Northern; Blotting, Western; Cell Fractionation; Cells, Cultured; Cytochrome P-45 | 1996 |
The effects of the ergosteroid 7-oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis.
Topics: Animals; Cell Respiration; Dehydroepiandrosterone; Glycerophosphates; Hyperthyroidism; Hypothyroidis | 1997 |
Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism.
Topics: Adult; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Hyperthyroidism; Hypo | 2000 |
Serum concentration of androstenediol and androstenediol sulfate in patients with hyperthyroidism and hypothyroidism.
Topics: Adult; Androstenediol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Hyper | 2001 |
Dehydroepiandrosterone sulphate is increased and dehydroepiandrosterone-response to corticotrophin-releasing hormone is decreased in the hyperthyroid state compared with the euthyroid state.
Topics: Adrenocorticotropic Hormone; Adult; Antithyroid Agents; Area Under Curve; Corticotropin-Releasing Ho | 2001 |
Implications of ultrasonically diagnosed polycystic ovaries. II. Studies of dynamic and pulsatile hormonal patterns.
Topics: Adrenal Glands; Adult; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Fo | 1992 |
Effect of thyroid funtion and of obesity on discriminant function for mammary carcinoma.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Aged; Androgens; Androsterone; Breast Neoplasms; | 1968 |
The determination of urinary pregnanetriol and the neutral 17-ketosteroids by gas-liquid chromatography.
Topics: 17-Ketosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adre | 1971 |
[Changes in indexes of nonbound thyroxine and of blood metabolites following administration of antiandrogens (Cyproterone), dehydroepiandrosterone, prednisone, L-triiodothyronine, D-thyroxine and in acromegaly].
Topics: 17-Hydroxycorticosteroids; Acromegaly; Adult; Binding Sites; Dehydroepiandrosterone; Female; Humans; | 1972 |
[Gas liquid chromatography analysis of urinary neutral steroid fractions in normal persons and patients with various diseases].
Topics: 17-Ketosteroids; Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormon | 1970 |